Cargando…

The Long Road of Immunotherapeutics against Multiple Sclerosis †

This commentary highlights novel immunomodulation and vaccine-based research against multiple sclerosis (MS) and reveals the amazing story that triggered this cutting-edge MS research in Greece and worldwide. It further reveals the interest and solid support of some of the world’s leading scientists...

Descripción completa

Detalles Bibliográficos
Autores principales:	Apostolopoulos, Vasso, Rostami, Abdolmohamad, Matsoukas, John
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2020
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7287601/ https://www.ncbi.nlm.nih.gov/pubmed/32403377 http://dx.doi.org/10.3390/brainsci10050288

Ejemplares similares

Advances in Multiple Sclerosis Research–Series I
por: Apostolopoulos, Vasso, et al.
Publicado: (2020)

Streptococcusthermophilus ST285 Alters Pro-Inflammatory to Anti-Inflammatory Cytokine Secretion against Multiple Sclerosis Peptide in Mice
por: Dargahi, Narges, et al.
Publicado: (2020)

Design of Linear and Cyclic Mutant Analogues of Dirucotide Peptide (MBP(82–98)) against Multiple Sclerosis: Conformational and Binding Studies to MHC Class II
por: Deraos, George, et al.
Publicado: (2018)

Multiple Sclerosis: Immunopathology and Treatment Update
por: Dargahi, Narges, et al.
Publicado: (2017)

The Use of Electrochemical Voltammetric Techniques and High-Pressure Liquid Chromatography to Evaluate Conjugation Efficiency of Multiple Sclerosis Peptide-Carrier Conjugates
por: Deskoulidis, Efstathios, et al.
Publicado: (2020)

Novel Approaches in the Immunotherapy of Multiple Sclerosis: Cyclization of Myelin Epitope Peptides and Conjugation with Mannan
por: Matsoukas, John M., et al.
Publicado: (2021)

Could DIZE be the answer to COVID-19?
por: Qaradakhi, Tawar, et al.
Publicado: (2020)

Myelin Peptide–Mannan Conjugate Multiple Sclerosis Vaccines: Conjugation Efficacy and Stability of Vaccine Ingredient
por: Matsoukas, John, et al.
Publicado: (2021)

Mannosylated Linear and Cyclic Single Amino Acid Mutant Peptides Using a Small 10 Amino Acid Linker Constitute Promising Candidates Against Multiple Sclerosis
por: Day, Stephanie, et al.
Publicado: (2015)

Smart therapies against global pandemics: A potential of short peptides
por: Apostolopoulos, Vasso, et al.
Publicado: (2022)

Vaccine Delivery Methods into the Future
por: Apostolopoulos, Vasso
Publicado: (2016)

Cancer Vaccines: Research and Applications
por: Apostolopoulos, Vasso
Publicado: (2019)

The Human Myelin Proteome and Sub-Metalloproteome Interaction Map: Relevance to Myelin-Related Neurological Diseases
por: Chasapis, Christos T., et al.
Publicado: (2022)

Anti-CD20 Agents for Multiple Sclerosis: Spotlight on Ocrelizumab and Ofatumumab
por: Florou, Despoina, et al.
Publicado: (2020)

Omicron variant (B.1.1.529) of SARS-CoV-2: Threat for the elderly?
por: Chavda, Vivek P, et al.
Publicado: (2022)

Mucormycosis – An opportunistic infection in the aged immunocompromised individual: A reason for concern in COVID-19
por: Chavda, Vivek P., et al.
Publicado: (2021)

Rare monkeypox: Is it really a threat to the elderly?
por: Chavda, Vivek P., et al.
Publicado: (2022)

A Veterinary Vaccine for SARS-CoV-2: The First COVID-19 Vaccine for Animals
por: Chavda, Vivek P, et al.
Publicado: (2021)

From Angiotensin II to Cyclic Peptides and Angiotensin Receptor Blockers (ARBs): Perspectives of ARBs in COVID-19 Therapy
por: Matsoukas, John, et al.
Publicado: (2021)

Effects of Vaccination with Altered Peptide Ligand on Chronic Pain in Experimental Autoimmune Encephalomyelitis, an Animal Model of Multiple Sclerosis
por: Tian, David H., et al.
Publicado: (2013)

Checkpoint Markers and Tumor Microenvironment: What Do We Know?
por: Ephraim, Ramya, et al.
Publicado: (2022)

Risks and risk management in modern multiple sclerosis immunotherapeutic treatment
por: Klotz, Luisa, et al.
Publicado: (2019)

Development of Methamphetamine Conjugated Vaccine through Hapten Design: In Vitro and In Vivo Characterization
por: Hossain, Md Kamal, et al.
Publicado: (2023)

COVID-19 Vaccines in the Pipeline, Are Antibodies Adequate?
por: Hossain, Md Kamal, et al.
Publicado: (2021)

The Long and Winding Road
por: Kalantar Motamedi, Mohammad Hosein
Publicado: (2012)

COVID-19 — The Long Road to Recovery
por: Morley, John E.
Publicado: (2020)

COVID-19 — The Long Road to Recovery
por: Morley, John E.
Publicado: (2020)

Nutritional Interventions for COVID-19: A Role for Carnosine?
por: Feehan, Jack, et al.
Publicado: (2021)

New Advances in Short Peptides: Looking Forward
por: Apostolopoulos, Vasso, et al.
Publicado: (2022)

Peptide-Based Immunotherapeutics and Vaccines
por: Reche, Pedro A., et al.
Publicado: (2014)

Immunotherapeutic Targeting in Autoimmune Diseases
por: Janikashvili, Nona, et al.
Publicado: (2016)

Role of Angiotensin II in Cardiovascular Diseases: Introducing Bisartans as a Novel Therapy for Coronavirus 2019
por: Swiderski, Jordan, et al.
Publicado: (2023)

Novel Oncology Therapeutics: Targeted Drug Delivery for Cancer
por: Tzakos, Andreas G., et al.
Publicado: (2013)

W254 in furin functions as a molecular gate promoting anti-viral drug binding: Elucidation of putative drug tunneling and docking by non-equilibrium molecular dynamics
por: Ridgway, Harry, et al.
Publicado: (2023)

The road to conception for women with multiple sclerosis
por: Sadovnick, Dessa, et al.
Publicado: (2021)

Receptor Interactions of Angiotensin II and Angiotensin Receptor Blockers—Relevance to COVID-19
por: Moore, Graham J., et al.
Publicado: (2021)

Peptide-Based Immunotherapeutics and Vaccines 2015
por: Reche, Pedro, et al.
Publicado: (2015)

Peptide-Based Immunotherapeutics and Vaccines 2017
por: Reche, Pedro, et al.
Publicado: (2018)

Molecular Epidemiology of SARS-CoV-2: The Dominant Role of Arginine in Mutations and Infectivity
por: Ridgway, Harry, et al.
Publicado: (2023)

Immunotherapy and NSCLC: The Long and Winding Road
por: Rossi, Antonio
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_ln39g0s7kqeuuv8maq6egie82k